Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Topics
Norilsk Nickel
Calendar
prev next February 2024
Mon Tue Wed Thu Fri Sat Sun
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29
20.11.2018
Over the next five years Norilsk Nickel will increase nickel and palladium production volumes
The company aims to benefit from an expected demand rise on the part of electric vehicle manufacturers.
More Topics Norilsk Nickel
03.10.2018
Norilsk Nickel ranked top 5 among Russia’s largest exporting companies
Expert, a magazine, recently published its annual ranking of Russia’s largest exporters for 2017, listing Norilsk Nickel as number five. The commentary on the ranking notes that in 2017 the company’s [export] growth increased more than twofold, bringing it to up four places to number five.
More Topics Norilsk Nickel
06.08.2018
GRIPPOL® QUADRIVALENT: THE FIRST 4-VALENT INFLUENZA PREVENTION VACCINE AUTHORIZED IN RUSSIA
In July 2018, Petrovax Pharm received Marketing Authorization No. LP-004951 for Grippol® Quadrivalent, a 4-valent inactivated subunit adjuvanted vaccine designed for prevention of influenza. It is the most advanced flu vaccine in the world that employs an antigen sparing technology and has a high preventive activity and safety.
More Topics Petrovax Pharm
16.07.2018
INTERROS AND PETROVAX PHARM HOSTED A ROUND TABLE «WE AND VIRUSES: EVOLUTIONARY SELECTION»
The event took place within the framework of the educational project «We and Media». Participants of the round table discussed ways of fighting dangerous infectious diseases and the role of the media in the popularization of the vaccine prophylaxis.
More Topics Petrovax Pharm
11.06.2018
NORILSK NICKEL IS LEADER IN THE EXTEL SURVEY- 2018 RATING
The rating is put together annually by Extel, a British company that studies the global investment climate.
More Topics Norilsk Nickel
12345